(4R)-8-[8-(2,4-dichlorophenyl)sulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-8-azaspiro[4.5]decan-4-amine
C20H22Cl2N6S — CID 139427224
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-8-[8-(2,4-dichlorophenyl)sulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-8-azaspiro[4.5]decan-4-amine
(4R)-8-[8-(2,4-dichlorophenyl)sulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-8-azaspiro[4.5]decan-4-amine (PubChem CID 139427224) has the molecular formula C20H22Cl2N6S and a molecular weight of 449.41 g/mol. Its IUPAC name is (4R)-8-[8-(2,4-dichlorophenyl)sulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-8-azaspiro[4.5]decan-4-amine.
Molecular Properties
| Compound Name | (4R)-8-[8-(2,4-dichlorophenyl)sulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-8-azaspiro[4.5]decan-4-amine |
|---|---|
| PubChem CID | 139427224 |
| Molecular Formula | C20H22Cl2N6S |
| Molecular Weight | 449.41 g/mol |
| Exact Mass | 448.10 |
| IUPAC Name | (4R)-8-[8-(2,4-dichlorophenyl)sulfanyl-[1,2,4]triazolo[4,3-c]pyrimidin-5-yl]-8-azaspiro[4.5]decan-4-amine |
| SMILES | N[C@@H]1CCCC12CCN(c1ncc(Sc3ccc(Cl)cc3Cl)c3nncn13)CC2 |
| InChI | InChI=1S/C20H22Cl2N6S/c21-13-3-4-15(14(22)10-13)29-16-11-24-19(28-12-25-26-18(16)28)27-8-6-20(7-9-27)5-1-2-17(20)23/h3-4,10-12,17H,1-2,5-9,23H2/t17-/m1/s1 |
| InChIKey | WWUYODROFUDOPW-QGZVFWFLSA-N |
| XLogP | 4.68 |
| TPSA | 72.34 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.41 |
| LogP ≤ 5 | 4.68 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139427224 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.